The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy (original) (raw)

• Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295–1300 (1997).
  Article CAS Google Scholar
• Wong, J.K. et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291– 1295 (1997).
  Article CAS Google Scholar
• Chun, T-W. et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94, 13193–13197 (1997).
  Article CAS Google Scholar
• Chun, T-W. et al. In vivo fate of HIV-1 infected cells: quantitative analysis of the transition to stable latency. Nature Med. 1, 1284–1290 (1995).
  Article CAS Google Scholar
• Chun, T-W. et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183 –188 (1997).
  Article CAS Google Scholar
• Ho, D.D. Toward HIV eradication or remission: the tasks ahead. Science 280, 1866–1867 (1998).
  Article CAS Google Scholar
• Zhang, L. et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 340, 1605–1613 (1999).
  Article CAS Google Scholar
• Michie, C.A., McLean, A., Alcock, B. & Beverley, P.C. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360, 264–265 (1992).
  Article CAS Google Scholar
• Hellerstein, M. et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Med. 5, 83–89 (1999).
  Article CAS Google Scholar
• Mohri, H., Bonhoeffer, S., Monard, S., Perelson, A.S., Ho, D.D. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279, 1223–1227 (1998).
  Article CAS Google Scholar
• Finzi, D. et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Med. 5, 512–517 ( 1999).
  Article CAS Google Scholar
• Macken, C.A. Design and analysis of serial limiting dilution assays with small sample sizes . J. Immunol. Meth. 222, 13– 29 (1999).
  Article CAS Google Scholar
• Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M., Ho, D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span and viral generation time. Science 271, 1582–1586 ( 1996).
  Article CAS Google Scholar
• Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection . Nature 373, 117–122 (1995).
  Article CAS Google Scholar
• Ho, D.D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123– 126 (1995).
  Article CAS Google Scholar
• Perelson, A.S. et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 387, 188– 191 (1997).
  Article CAS Google Scholar
• Furtado, M.R. et al. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 340, 1614–1622 ( 1999).
  Article CAS Google Scholar
• Natarajan, V. et al. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Lancet 353, 119– 120 (1999).
  Article CAS Google Scholar
• Lewin, S.R. et al. The use of real-time PCR and molecular beacons to detect virus replication in HIV-1 infected individuals on prolonged effective antiretroviral therapy. J. Virol. 73, 6099– 6103 (1999).
  CAS PubMed PubMed Central Google Scholar
• Gunthard, H.F. et al. Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol. Virology 259, 154–165 ( 1999).
  Article CAS Google Scholar
• Altice, F.L. & Friedland, G.H. The era of adherence to HIV therapy. Ann. Intern. Med. 129, 503– 505 (1998).
  Article CAS Google Scholar
• Lucas, G.M., Chaisson, R.E. & Moore, R.D. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann. Intern. Med. 131, 81–87 (1999).
  Article CAS Google Scholar
• Palella, F.J. et al. Declining morbidity and mortality among patients with advanced human immunodeficiency. N. Engl. J. Med. 338, 853–860 (1998).
  Article Google Scholar
• Ortiz, G.M. et al. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of HAART. J. Clin. Invest. 104, –R13–R18 (1999).
  Article CAS Google Scholar
• Chun, T-W. et al. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nature Med. 5, 651–655 (1999).
  Article CAS Google Scholar